Hypovitaminosis D and insulin resistance in peritoneal dialysis patients

International Urology and Nephrology

Volumn 43, Issue 2, 2011, Pages 527-534

  Bindal, Mehmet E ^a   Taskapan, Hulya ^a  

^a INONU UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

25 (OH) D; Dialysis; Insulin Resistance; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; PARATHYROID HORMONE; VITAMIN D;

ADULT; ARTICLE; BODY FAT; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HORMONAL REGULATION; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; PERITONEAL DIALYSIS; RISK FACTOR; TREATMENT DURATION; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY;

ADULT; FEMALE; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED; PERITONEAL DIALYSIS; PROSPECTIVE STUDIES; VITAMIN D DEFICIENCY;

EID: 79959707186     PISSN: 03011623     EISSN: 15732584     Source Type: Journal    
DOI: 10.1007/s11255-010-9813-9     Document Type: Article

References (37)

1. Tangpricha V, Pearce EN, Chen TC et al (2002) Vitamin D insufficiency among free-living healthy young adults. Am J Med 112(8):659-662 (Pubitemid 34597167)
2. Van der Wielen RP, Lowik MR, Van den Berg H et al (1995) Serum vitamin D concentrations among elderly people in Europe. Lancet 346:207-210
3. Chiu KC, Chu A, Go VL, Saad MF (2004) Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr 79(5):820
4. Mertens PR, Müller R (2009) Vitamin D and cardiovascular risk. Int Urol Nephrol (Epub ahead of print)
5. Neves PL, Malho A, Cabrita A, Pinho A, Baptista A, Morgado E, Faísca M, Carrasqueira H, Silva AP (2009) Statins and vitamin D: a friendly association in pre-dialysis patients. Int Urol Nephrol (Epub ahead of print)
6. Rammos G, Tseke P, Ziakka S (2008) Vitamin D, the renin-angiotensin system, and insulin resistance. Int Urol Nephrol 40(2):419-426 (review)
7. Taskapan H, Wei M, Oreopoulos DG (2006) 25(OH) Vitamin D(3) in patients with chronic kidney disease and those on dialysis: rediscovering its importance. Int Urol Nephrol 38(2):323-329 (Pubitemid 44138161)
8. Taskapan H, Ersoy FF, Passadakis P, Tam P, Memmos D, Katopodis K, Ozener C, Akcicek F, Camsari T, Ates K, Ataman R, Vlachojannis JG, Dombros N, Utas C, Akpolat T, Bozfakioglu S, Wu GG, Karayaylali I, Arinsoy T, Stathakis Ch, Yavuz M, Tsakiris D, Dimitriades A, Yilmaz ME, Gültekin M, Karayalçin B, Polat N, Oreopoulos DG (2006) Severe vitamin D deficiency in chronic renal failure patients on peritoneal dialysis. Clin Nephrol Clin Nephrol 66(4):247-255 (Pubitemid 44541211)
9. Taskapan H, Ersoy FF, Passadakis P, Tam P, Memmos D, Katopodis K, Ozener C, Akcicek F, Camsari T, Ates K, Ataman R, Vlachojannis JG, Dombros N, Utas C, Akpolat T, Bozfakioglu S, Wu GG, Karayaylali I, Arinsoy T, Stathakis Ch, Yavuz M, Tsakiris D, Dimitriades A, Yilmaz ME, Gültekin M, Karayalçin B, Polat N, Oreopoulos DG (2005) Body pain during daily activities in patients on peritoneal dialysis. Dial Transplant 2:58-72
10. Scragg R, Sowers M, Bell C (2004) Serum 25-Hydroxyvitamin D, Diabetes, and ethnicity in the Third National Health and Nutrition Examination Survey. Diabetes Care 27:2813-2818
11. DeFronzo RA, Alvestrand A, Smith D, Hendler R, Hendler E, Wahren J (1981) Insulin resistance in uremia. J Clin Invest 67:563-568 (Pubitemid 11141740)
12. Pittas AG, Harris SS, Stark PC, Dawson-Hughes B (2007) The effects of calcium and vitamin D supplementation on blood glucose and markers of ?nflammation in nondiabetic adults. Diabetes Care 30:980-986 (Pubitemid 46556596)
13. Mak RHK (1992) Amelioration of hypertension and insulin resistance by 1, 25-dihydroxycholecalciferol in hemodialysis patients. Pediatr Nephrol 6:345-348
14. Mak RHK (1992) Intravenous 1, 25 dihydroxycholecalciferol corrects glucose intolerance in hemodialysis patients. Kidney Int 41:1049-1054
15. Türk S, Yeksan M, Tamer N, Gürbilek M, Erdogan Y, Erkul Ï (1992) Effect of 1, 25 (OH)2 D3 treatment on glucose intolerance in uraemia. Nephrol Dial Transplant 7:1207-1212
16. Gunal AI, Celìker H, Celebì H, Ustundag B, Gunal SY (1997) Intravenous alfacalcidol improves insulin resistance in hemodialysis patients. Clin Nephrol 48:109-113 (Pubitemid 27371040)
17. Lin S, Lin Y, Lu K, Diang L, Chyr S, Liao W, Shieh S (1994) Effects of intravenous calcitriol on lipid profiles and glucose tolerance in uraemic patients with secondary hyperparathyroidism. Clin Sci 87:533-538 (Pubitemid 24353467)
18. Mak RHK (1998) 1, 25-dihydroxyvitamin D3 corrects insulin and lipid abnormalities in uremia. Kidney Int 53:1353-1357
19. Strózecki P, Kretowicz M, Odrow-Sypniewska G, Manitius J (2004) The influence of intravenous 1, 25(OH)2D3 therapy on glucose metabolism in hemodialyzed patients with secondary hyperparathyroidism. Ren Fail 26:345-348 (Pubitemid 39167608)
20. Blair D, Byham-Gray L, Lewis E, McCaffrey S (2008) Prevalence of vitamin D [25(OH)D] deficiency and effects of supplementation with ergocalciferol (vitamin D2) in stage 5 chronic kidney disease patients. J Ren Nutr 18:375-382 (Pubitemid 351818240)
21. Kautzky-Willer A, Pacini G, Barnas U, Ludvik B, Streli C, Graf H, Prager R (1995) Intravenous calcitriol normalizes insulin sensitivity in uremic patients. Kidney Int 47:200-206
22. Wolf M, Shah A, Gutierrez O, Ankers E, Monroy M, Tamez H, Steele D, Chang Y, Camargo CA Jr, Tonelli M, Thadhani R (2007) Vitamin D levels and early mortality among incident hemodialysis patients. Kidney Int 72:1004-1013 (Pubitemid 47530570)
23. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419 (Pubitemid 15018832)
24. Inzucchi SE, Maggs DG, Spollett GR, Page SL, Rife FS, Walton V, Shulman GI (1998) Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus. 338(13):867-872
25. Bonakdaran S, Ayatollahi H, Mojahedi MJ, Sharifipoor F, Shakeri M (2008) Impact of treatment with oral calcitriol on glucose intolerance and dyslipidemia(s) in hemodialysis patients. Saudi J Kidney Dis Transpl 19(6):942-947
26. Holick MF (2003) Vitamin D: a millenium perspective. J Cell Biochem 88:296-307
27. Smith EL, Walworth ND, Holick MF (1986) Effect of 1, 25-dihydroxyvitamin D3 on the morphologic and biochemical differentiation of cultured human epidermal keratinocytes grown in serum-free conditions. J Invest Dermatol 86:709-714 (Pubitemid 16098227)
28. Dusso AS, Finch J, Brown A et al (1991) Extrarenal production of calcitriol in normal and uremic humans. J Clin Endocrinol Metab 72:157-164 (Pubitemid 21921670)
29. Stumpf WE, Sar M, Reid FA et al (1979) Target cells for 1, 25-dihydroxyvitamin D3 in intestinal tract, stomach, kidney, skin, pituitary, and parathyroid. Science 206:1188-1190 (Pubitemid 10159658)
30. Dusso A, Lopez-Hilker S, Rapp N, Slatopolsky E (1988) Extra-renal production of calcitriol in chronic renal failure. Kidney Int 34:368-375
31. Lambert PW, Stern PH, Avioli RC et al (1982) Evidence for extrarenal production of 1 alpha, 25-dihydroxyvitamin D in man. J Clin Invest 69:722-725 (Pubitemid 12184971)
32. Pettifor JM, Bikle DD, Cavaleros M et al (1995) Serum levels of free 1, 25-dihydroxyvitamin D in vitamin toxicity. Ann Intern Med 122(7):5111-5133
33. Guilherme A, Virbasius JV, Puri V et al (2008) Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat Rev Mol Cell Biol 9:367-377 (Pubitemid 351574198)
34. Ozcan U, Cao Q, Yilmaz E et al (2004) Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science 306:457-461 (Pubitemid 39372439)
35. Trirogoff ML, Shintani A, Himmelfarb J et al (2007) Body mass index and fat mass are the primary correlates of insulin resistance in nondiabetic stage 3-4 chronic kidney disease patients. Am J Clin Nutr 86:1642-1648 (Pubitemid 350232178)
36. Sanches FM, Avesani CM, Kamimura MA et al (2008) Waist circumference and visceral fat in CKD: a cross-sectional study. Am J Kidney Dis 52(1):66-73 (Pubitemid 351853257)
37. Axelsson J, Rashid Qureshi A, Suliman ME et al (2004) Truncal fat mass as a contributor to inflammation in end-stage renal disease. Am J Clin Nutr 80:1222-1229 (Pubitemid 41350682)